The investigation of allele and genotype frequencies of human C3 (rs2230199) in south Iranian population

[1]  I. Wilson,et al.  Complement polymorphisms: geographical distribution and relevance to disease. , 2012, Immunobiology.

[2]  J. Attia,et al.  Human Genome Epidemiology (HuGE) Review Systematic Review and Meta-Analysis of the Association Between Complement Component 3 and Age-related Macular Degeneration: A HuGE Review and Meta- Analysis , 2011 .

[3]  N. Azarpira,et al.  The investigation of allele and genotype frequencies of CYP3A5 (1*/3*) and P2Y12 (T744C) in Iran , 2011, Molecular Biology Reports.

[4]  Brian Y. Hwang,et al.  Polymorphisms in complement component 3 (C3F) and complement factor H (Y402H) increase the risk of postoperative neurocognitive dysfunction following carotid endarterectomy , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[5]  Negar Azarpira,et al.  Investigation of allele and genotype frequencies of CYP 2 C 9 , CYP 2 C 19 and VKORC 1 in Iran , 2010 .

[6]  Guillaume Laval,et al.  Formulating a Historical and Demographic Model of Recent Human Evolution Based on Resequencing Data from Noncoding Regions , 2010, PloS one.

[7]  Jeremiah D. Degenhardt,et al.  Targets of balancing selection in the human genome. , 2009, Molecular biology and evolution.

[8]  Kirk E Lohmueller,et al.  Detecting ancient admixture and estimating demographic parameters in multiple human populations. , 2009, Molecular biology and evolution.

[9]  A. Hofman,et al.  Complement component C3 and risk of age-related macular degeneration. , 2008, Ophthalmology.

[10]  Kosuke M. Teshima,et al.  Natural Selection on Genes that Underlie Human Disease Susceptibility , 2008, Current Biology.

[11]  J. Haines,et al.  C3 R102G polymorphism increases risk of age-related macular degeneration. , 2008, Human molecular genetics.

[12]  A. Ghaderi,et al.  HLA class II similarities in Iranian Kurds and Azeris , 2007, International journal of immunogenetics.

[13]  I. Deary,et al.  Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.

[14]  A. Khelil,et al.  Polymorphisme du C3 du complément chez des patients atteints de bronchopneumopathie chronique obstructive en Tunisie , 2007 .

[15]  Shamil R Sunyaev,et al.  Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. , 2007, American journal of human genetics.

[16]  G. Lefranc,et al.  [C3 complement polymorphism in patients suffering from obstructive chronic bronchopneumopathy in Tunisia]. , 2007, Annales de biologie clinique.

[17]  L. Pereira-Ferrari,et al.  Mannan‐binding lectin plasma levels in leprosy: deficiency confers protection against the lepromatous but not the tuberculoid forms , 2006, Clinical and experimental immunology.

[18]  Xavier Bossuyt,et al.  Mannose-binding lectin genotype and invasive pneumococcal infection. , 2006, Human immunology.

[19]  R. Vaughan,et al.  Influence of donor C3 allotype on late renal-transplantation outcome. , 2006, The New England journal of medicine.

[20]  D. Charlesworth.  Balancing Selection and Its Effects on Sequences in Nearby Genome Regions , 2006, PLoS genetics.

[21]  E. Reis,et al.  Clinical Aspects and Molecular Basis of Primary Deficiencies of Complement Component C3 and its Regulatory Proteins Factor I and Factor H , 2006, Scandinavian journal of immunology.

[22]  S. Thiel,et al.  Clinical manifestations of mannan-binding lectin deficiency , 2005, Molecular Immunology.

[23]  A. Crampin,et al.  Large-scale candidate gene study of tuberculosis susceptibility in the Karonga district of northern Malawi. , 2004, The American journal of tropical medicine and hygiene.

[24]  H. Delbrück,et al.  Genetic polymorphism of C3 and serum levels of immunoglobulins, C3, C4 components of complement and C3-proactivator in four different populations of Afghanistan , 1976, Human Genetics.

[25]  A. Kok-Jensen,et al.  Mannose-binding lectin polymorphisms in clinical tuberculosis. , 2003, The Journal of infectious diseases.

[26]  G. Kronborg,et al.  Mannose-binding lectin genotype as a risk factor for invasive pneumococcal infection , 2002, The Lancet.

[27]  K. Welsh,et al.  MBL genotype and risk of invasive pneumococcal disease: a case-control study , 2002, The Lancet.

[28]  P. Mathieson,et al.  Molecular analysis of C3 allotypes in patients with systemic vasculitis. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  M. Petzl-Erler,et al.  BF and C3 genetic polymorphisms in Kaingang Indians from southern Brazil. , 1992, Human heredity.

[30]  M. Walport,et al.  Molecular basis of polymorphisms of human complement component C3 , 1990, The Journal of experimental medicine.

[31]  L. Caenazzo,et al.  Genetic polymorphism of C3 in the Veneto population, Italy. , 1989, Anthropologischer Anzeiger; Bericht uber die biologisch-anthropologische Literatur.

[32]  C. Damodaran,et al.  C3 polymorphism in Kotas and Badagas of Nilgiri Hills, south India. , 1988, Gene geography : a computerized bulletin on human gene frequencies.

[33]  C. Stringer,et al.  Genetic and fossil evidence for the origin of modern humans. , 1988, Science.

[34]  G. Vona,et al.  Gc and C3 polymorphisms in Central Sardinia. , 1988, Human heredity.

[35]  T. Welch,et al.  C3 alleles in diseases associated with C3 activation. , 1987, Disease markers.

[36]  M. Rambausek,et al.  Genetic polymorphism of C3 and Bf in IgA nephropathy. , 1987, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[37]  O. Smithies,et al.  Genetic Polymorphism of C'3(β1c-Globuiin) in Human Serum , 1968, Science.

[38]  C. Alper,et al.  Genetic polymorphism of the third component of human complement (C'3). , 1968, The Journal of clinical investigation.

[39]  R. Wieme,et al.  Genetically Determined Electrophoretic Variant of the Human Complement Component C′3 , 1967, Nature.